...
首页> 外文期刊>neurochemical research >Characterization of 3Hcholecystokinin octapeptide binding to mouse brain synaptosomes: Effects of neuroleptics
【24h】

Characterization of 3Hcholecystokinin octapeptide binding to mouse brain synaptosomes: Effects of neuroleptics

机译:Characterization of 3Hcholecystokinin octapeptide binding to mouse brain synaptosomes: Effects of neuroleptics

获取原文
           

摘要

The presence of high concentrations of both dopamine and cholecystokinin (CCK) in the striatum and in various limbic structures suggests that the CCK may not only influence dopaminergic transmission, but it also may be relevant to the psychopathology of schizophrenia and to the therapeutic effects of neuroleptics. By using a synaptosomal fraction isolated from the mouse cerebral cortex and propionyl-3HCCK8-sulphate (3HCCK8S) as a ligand, a single binding site for 3HCCK8 with aKdvalue of 1.04 nM and aBmaxvalue of 42.9 fmol/mg protein was identified. The competitive inhibition of 3HCCK8S binding by related peptides produced an order of potency of CCK8-sulphated (IC50=5.4 nM)>CCK8-unsulfated (IC50=40 nM) and>CCK4 (IC50=125 nM). The regional distribution of 3HCCK8S binding in the mouse brain was highest in the olfactory bulb (34.3±5.6 fmol/mg protein)>cerebral cortex>cerebellum>olfactory tubercle>striatum>pons-medulla>mid brain>hippocampus>hypothalamus (12.4±2.1 fmol/mg protein). The repeated administration of haloperidol (2.5 mg/kg/tid) increased the binding of 3HCCK8S in cerebral cortex from 31.8±1.7 to 38.9±5.2 fmol/mg protein. The varied distribution of CCK8S receptors may signify nonuniform functions for the octapeptide in the br

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号